- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-859X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Primary care use of antipsychotic drugs: an audit and intervention study ; volume:4 ; number:1 ; day:29 ; month:11 ; year:2005 ; pages:1-8 ; date:12.2005
Annals of general psychiatry ; 4, Heft 1 (29.11.2005), 1-8, 12.2005
- Creator
-
Mortimer, Ann M.
Shepherd, Charles J.
Rymer, Michael
Burrows, Alison
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1744-859X-4-18
- URN
-
urn:nbn:de:101:1-2019071821242161333258
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mortimer, Ann M.
- Shepherd, Charles J.
- Rymer, Michael
- Burrows, Alison
- SpringerLink (Online service)
Other Objects (12)
Hypothermia following antipsychotic drug use
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Genetic determinants of antidepressant and antipsychotic drug response
Repositioning of the antipsychotic drug TFP for sepsis treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
A retrospective study of antipsychotic drug switching in a pediatric population
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Risk of weight gain for specific antipsychotic drugs: a meta-analysis
Measurement without management: qualitative evaluation of a voluntary audit & feedback intervention for primary care teams
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Risk factors and pattern of weight gain in youths using antipsychotic drugs
Hypothermia following antipsychotic drug use
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Genetic determinants of antidepressant and antipsychotic drug response
Repositioning of the antipsychotic drug TFP for sepsis treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
A retrospective study of antipsychotic drug switching in a pediatric population
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Risk of weight gain for specific antipsychotic drugs: a meta-analysis
Measurement without management: qualitative evaluation of a voluntary audit & feedback intervention for primary care teams
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Risk factors and pattern of weight gain in youths using antipsychotic drugs
Hypothermia following antipsychotic drug use
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Genetic determinants of antidepressant and antipsychotic drug response
Repositioning of the antipsychotic drug TFP for sepsis treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
A retrospective study of antipsychotic drug switching in a pediatric population
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Risk of weight gain for specific antipsychotic drugs: a meta-analysis
Measurement without management: qualitative evaluation of a voluntary audit & feedback intervention for primary care teams
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016